Kayano Moriyama

809 citations
13 papers · 641 indexed · h-index 9

Kayano Moriyama

13 papers receiving 634 citations

Peers

Kayano Moriyama
Comparison fields: 5 of 71
  • Immunology and Allergy 317
  • Cancer Research 236
  • Cell Biology 158
  • Hematology 95
  • Oncology 183
Replace Cynthia E. Wilkins-Port with:
Cynthia E. Wilkins-Port United States
Julius Klominek Sweden
Tiina Hurskainen Finland
Yasutaka Hayashido Japan
Jordi Esparza Spain
Rebecca A. Wagenaar-Miller United States
Lewis V. Owens United States
Ron Zeheb United States
Rachel Bar‐Shavit Israel
Louise Westberg Strejby Christensen Denmark
Kayano Moriyama relative to Cynthia E. Wilkins-Port United States Cynthia E. Wilkins-Port's profile →
Citations per field
00.5×2.6×
Cynthia E. Wilkins-Port · 1×
Citations per year

Countries citing papers authored by Kayano Moriyama

Since Specialization
Citations

This map shows the geographic impact of Kayano Moriyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kayano Moriyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kayano Moriyama more than expected).

Fields of papers citing papers by Kayano Moriyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kayano Moriyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kayano Moriyama. The network helps show where Kayano Moriyama may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kayano Moriyama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kayano Moriyama Line = papers co-authored together Kayano Moriyama links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 20241
2 20241
3 20233
4 20233
5 200937
6 200523
7 200231
8 200074
9 199919
10
Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells.
1999184
11 199879
12 1998102
13 199884

About Kayano Moriyama

Kayano Moriyama is a scholar working on Immunology and Allergy, Cell Biology and Hematology, having authored 13 papers that have together received 641 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (7 papers), Protease and Inhibitor Mechanisms (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Platelet Disorders and Treatments (2 papers), Spaceflight effects on biology (2 papers), Muscle metabolism and nutrition (2 papers), Bone health and osteoporosis research (2 papers) and Cellular Mechanics and Interactions (2 papers). The work is most often cited by research in Immunology and Allergy (317 citations), Cancer Research (236 citations) and Cell Biology (158 citations). Kayano Moriyama has collaborated with scholars based in Japan and United States. Frequent co-authors include Hiroto Mizushima, Kaoru Miyazaki, Naohiko Koshikawa, Yoji Nagashima, Hiroyuki Takamura, K. Miyazaki, Shunsuke Yanoma, Yoshiaki Tsubota, Tomomi Hirosaki and Fumiki Hirahara. Their work appears in journals such as Journal of Biological Chemistry, PEDIATRICS and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026